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Abstract 
Objective： A prominent stress reaction in the pelvis of women with endometriosis and 
the role of human heat shock protein 70 (HSP70) in inflammation and the growth of 
endometriosis has been recently demonstrated. We report here expression of HSP70 in 
tissues derived from GnRH agonist (GnRHa)-untreated and -treated women with 
adenomyosis and uterine myoma. 
Study Design: This is a case-controlled biological study. Biopsy specimens were 
collected from pathological lesions and eutopic endometria/autologous myometria of 30 
women with adenomyosis, 35 women with uterine myoma and 15 control women 
during laparoscopy, laparotomy and hysteroscopy. Fourteen women with adenomyosis 
and 20 women with uterine myoma were treated with GnRHa for a variable period of 
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3-6 months before surgery. The immunoexpressions of HSP70 and CD68-positive Mφ 
in endometria, lesions/myometria were examined by immunohistochemistry. The 
immunoreactivity of HSP70 in tissues was analyzed by quantitative-histogram (Q-H) 
scores. 
Results: Comparing to control women, HSP70 immunoexpression was significantly 
higher in endometria/myometria and pathological lesions of women with adenomyosis 
and myoma. A significant positive correlation between Q-H scores of HSP70 and 
CD68-positive Mφ numbers was found in the endometria derived from women with 
adenomyosis (r=0.388). Treatment with GnRHa significantly decreased Q-H scores of 
HSP70 in pathological lesions and endometria/myometria of women with adenomyosis 
and uterine myoma comparing to similar tissues derived from GnRHa-untreated 
women. 
Conclusion: A variable amount of tissue stress reaction occurred in endometria and 
pathological lesions of women adenomyosis and uterine myoma that can be effectively 
suppressed after GnRHa treatment. 
Keywords: adenomyosis, uterine myoma, HSP70, inflammation, GnRHa 
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Introduction 
Human heat-shock proteins (HSPs) function as molecular chaperons in 
general and are reported to be produced by macrophages (Mφ), vascular endothelial 
cells, smooth muscle cells, endometrial cells and other dendritic cells [1,2]. Molecular 
chaperons are critical for the folding and regulation of a wide array of cellular proteins 
(3). Heat shock proteins are the most representative group of chaperons. As a marker of 
tissue stress reaction, endogenous HSPs including HSP70 may be released under a wide 
variety of stressful stimuli such as heat shock, viral or bacterial infections, internal 
physical stress, chemical stress and pelvic inflammation [4,5]. Endometrial tissue 
breakdown during menstruation and neurogenic or painful stimuli may also elicit a 
stressful reaction to the tissues. 
Most of the published reports on HSPs described their expression in either 
endometrium or in endometriosis. A prominent stress reaction in the pelvis of women 
with endometriosis and the role of HSP70 in Toll-like receptor (TLR) 4-mediated 
inflammation and growth of endometriosis has been recently reported from our 
laboratory [6]. Persistent and changing inflammatory reaction in pelvic environment and 
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growth/invasion of cells may induce variable stress reaction in tissues derived from 
women with endometriosis. An additive effect between HSP70 and inflammation has 
been observed in a recent study [7]. Despite enough information on endometriosis, the 
detailed analysis of HSP70 immunoreactivity in adenomyosis or in uterine myoma is 
limited. 
The hyperplastic and/or hypertrophic changes of smooth muscle cells in 
response to the invaginating glands/stroma into the myometrium of patients with 
adenomyosis may exert stressful insult to the adenomytic lesions or to the surrounding 
myometrium. A similar pattern of tissue stress reaction may occur in the endometrium 
or myometrium in response to the growing myoma nodules. A differential inflammatory 
reaction in submucosal, intramural and subserosal myomas has been reported [8].
However, the tissue stress reaction and its association with tissue inflammatory reaction 
in women with adenomyosis and uterine myoma are yet to be investigated. 
In addition to pituitary suppression, we recently demonstrated that GnRHa has 
multiple biological functions in peripheral tissues of women with different reproductive 
diseases [9]. Since, GnRH receptors were expressed by both eutopic endometria and 
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pathological lesions of women with endometriosis, adenomyosis, and uterine myoma 
[9], we believe that multiple biological functions could be the direct tissue effect of 
GnRHa or indirect effect of GnRHa-mediated estrogen suppression. In fact, GnRHa was 
able to significantly suppress tissue inflammatory reaction, angiogenesis, cell 
proliferation and induced apoptosis in women with endometriosis, adenomyosis and 
uterine myoma [9]. In a separate study, suppression of HSP70 expression in response to 
GnRHa and in women with endometriosis has been recently reported [10]. However, the 
role of GnRHa in the tissue expression of HSP70 in women with adenomyosis and 
uterine myoma is unknown. 
Therefore, in the first part of our study, we aim to examine the tissue 
expression of human HSP70 in pathological lesions and endometria derived from 
GnRHa-untreated women with adenomyosis and uterine myomas. We speculated that 
infiltrating immune cells and micro-vessels within tissues might also suffer a variable 
amount of stress reaction. Therefore, secondly, we examined the co-localization of 
HSP70 and CD68 (Mφ marker) and von Willebrand factor (VWF, vessel marker) in 
the serial section of tissues derived from these women. Finally, we compared the pattern 
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of changes in the immunoreaction of HSP70 in pathological lesions and autologous 
endometria/myometria between GnRHa-treated and -untreated women with 
adenomyosis and uterine myoma. 
Materials and Methods 
Subjects. This is a case-controlled biological research using prospectively 
collected biopsy samples of women with and without adenomyosis/uterine myoma and 
their retrospective evaluation. The subjects in this study were women of reproductive 
age (age range 23-51yrs). From July 2009 to April 2012, biopsy specimens were 
collected from a total of 30 women with adenomyosis and 35 women with uterine 
myomas who underwent laparoscopy, laparotomy or hysteroscopy. All these fertile 
women were admitted to our hospital with the complaint of pelvic pain, dysmenorrhea, 
abnormal genital bleeding, hypermenorrhoea or anemia. The control group consisted of 
15 fertile women between 23 and 37 years of age without any evidence of peritoneal or 
ovarian endometriosis and operated on for dermoid cysts by laparoscopy. We selected 
patients with dermoid cysts as control group with the assumption that tissues of these 
patients may suffer less stress reaction (but not zero) than in tissues derived from other 
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reproductive diseases as demonstrated recently [6,11]. The diagnosis of adenomyosis 
and uterine fibroids in all these women was done by clinical manifestations, by 
ultrasonograghapy or magnetic resonance image before operation and subsequently 
confirmed by surgery and histopathology. The distribution of women who had GnRHa 
treatment for a period of 3-6 months is as follows: adenomyosis (n=14) and uterine 
myoma (n=20). Groups of women without GnRHa treatment in this study did not 
receive oral contraceptives or any other hormonal medication within 12 months prior to 
surgery. The phases of the menstrual cycle in women without hormonal therapy was 
determined by histological dating of eutopic endometrial samples taken simultaneously 
with pathological lesions derived from these women. 
Collection of biopsy specimens. Tissue samples from endometria of control 
women were collected at the time of laparoscopy. No hysterectomy was performed for 
control women. The visual absence of adenomyosis/uterine myoma in control women 
was confirmed by image. Biopsy specimens of adenomyotic lesions and autologous 
myometria from either anterior or posterior wall and corresponding endometria were 
obtained from 26 women with adenomyosis who underwent hysterectomy. Collection of 
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all samples of myometria in women with adenomyosis refers to myometria away from 
an adenomyotic lesion. We collected samples of only pathological lesions and 
endometria from four GnRHa-untreated women with adenomyosis who had 
conservative surgery with the purpose of future pregnancy. Biopsies were taken from 
nodules, endometria, and myometria of women with uterine myoma during 
hysteroscopic resection (n=5), laparoscopic myomectomy (n=10) or after hysterectomy 
(n=20). We collected samples of autologous myometrium from 20 women with myoma 
who underwent hysterectomy, 8 in GnRHa-untreated group and 12 in GnRHa-treated 
group. A total of three to four biopsy specimens from different anatomical locations 
(anterior wall, posterior wall, fundus) of the eutopic endometrium were also studied for 
women with adenomyosis and myoma who underwent hysterectomy. All collected 
biopsy specimens were prepared for formalin-fixed paraffin-embedded tissue blocks for 
subsequent histopathological and immunohistochemical study. The details of physical 
collection of tissue biopsies were reported elsewhere [12-15]. 
All biopsy specimens were collected in accordance with the guidelines of the 
Declaration of Helsinki and with the approval of the Nagasaki University Institutional 
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Review Board. A written informed consent was obtained from all women. 
Antibodies used. We performed immunohistochemical analysis to investigate 
the immunoreaction of HSP70, CD68 and VWF using respective antibodies against 
target antigen as follows: (1) HSP70 (marker of stress reactive protein, 1:500), rabbit 
polyclonal, Dako, Denmark; (2) CD68 [marker of macrophage (Mφ), 1:50], KP1, 
mouse monoclonal, Dako, Denmark; (3) von Willebrand factor (VWF, micro-vessel 
marker, 1:25), F8/86, M0616, mouse monoclonal, Dako, Denmark; (4) non-immune 
mouse immunoglobulin (Ig) G1 antibody (1:50, Dako) was used as a negative control. 
Immunohistochemistry. Details of immunohistochemical procedures are 
described elsewhere [13,16]. Briefly, 5μm thick paraffin embedded tissues were 
deparaffinized in xylene and rehydrated in phosphate buffered saline (PBS). After 
immersion in 0.3% H2O2/ methanol to block endogenous peroxidase activity, sections 
were pre-incubated with 10% normal goat serum to prevent non-specific binding and 
then incubated overnight at room temperature with respective antibody. The slides were 
subsequently incubated with biotinylated second antibody for 10 min, followed by 
incubation with avidin-peroxidase for 10 min and visualized with diaminobenzidine. 
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Finally, the tissue sections were counterstained with Mayers hematoxylin, dehydrated 
with serial alcohols, cleared in xylene and mounted. 
All immunoreactive cells and tissues were examined in five different fields of 
one section (x200 or x400) by light microscopy. Mφ numbers as immunoreactive to 
CD68 and total micro-vessel numbers as immunoreactive to VWF were counted. Total 
micro-vessel density of those areas that contained the highest number of capillaries and 
venules was analyzed. The intensity of HSP70-stained cells and numbers of 
CD68-stained Mφ per field in each biopsy specimen were examined and confirmed by 
a second observer (MK). 
Quantification of immunostained cells by Q-H score. The immunoreactive 
intensity of HSP70-stained gland cells, stromal cells and smooth muscle cells was 
quantified by a modified method of quantitative histogram scoring (Q-H score) as 
described previously [16-18]. The Q-H score was calculated using the following 
equation: Q-H score = Σpi (I + 1), where I = 1, 2 or 3 and pi is the percentage of stained 
cells for each intensity. The staining intensity was graded as 0 = no staining, 1 = weak, 2 
= moderate, and 3 = strong. We calculated the mean Q-H scores of five different fields 
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of one section by light microscopy at moderate magnification (×200). The authors were 
blinded to the study groups during quantification. 
As a main outcome measures, we investigated the pattern of changes in the 
tissue of expression of HSP70 in respective biopsy samples derived from 
GnRHa-treated and -untreated women with adenomyosis and uterine myoma. We also 
evaluated a panel of confounding variables such as, age, parity, phases of the menstrual 
cycle, severity of symptoms, presence of adenomyotic lesion/myoma nodule, and 
GnRHa treatment that might be involved as a potential source of tissue stress reaction 
and in the tissue expression of HSP70. 
Statistical Analysis. The clinical characteristics of the subjects were evaluated 
by one-way analysis of variance. All results are expressed as either mean ± SD or 
median and inter-quartile range (IQR). The differences between study group and control 
group, GnRHa-treated and -untreated group were compared using Mann-Whitney U-test 
or Student’s t test. For comparison among groups, the Kruskal-Wallis test was used. 
Pearson’s correlation coefficient was used to evaluate the relationship between two 
groups. Multiple analysis of covariance (ANCOVA) was performed to evaluate possible 
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confounding variables associated with tissue expression of HSP70. A p value <0.05 was 
considered statistically significant. 
Results 
The clinical profiles of control women, GnRHa-treated and -untreated women 
with adenomyosis and uterine myoma are shown in Table 1. The women with 
adenomyosis and uterine myoma were significantly older than control women (p<0.01 
for each). No age difference was observed between women with adenomyosis and 
uterine myoma or between GnRHa-treated and -untreated women (Table 1). We did not 
find any influence of age difference in the tissue expression of HSP70. There was no 
difference in the number of women presenting with pain, anemia, reproductive desire or 
body mass index among study groups (data not shown). The distribution in the phases 
of menstrual cycle in GnRHa-untreated women and type of uterine myomas are shown 
in Table 1. 
Immunoexpression of HSP70 in adenomyosis and uterine myoma. A 
moderate to strong imunoexpression of HSP70 was found in the control endometrium, 
adenomyotic lesions, myoma nodules and corresponding endometria or myometria 
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(Figure 1, A). HSP70 expression was found in both gland cells/stromal cells and smooth 
muscle cells derived from endometria, adenomyotic lesions/myoma nodules and 
myometria of women with adenomyosis and uterine myoma. Although we could not 
collect biopsy samples during the menstrual phases among these three groups of women, 
we found an apparent but insignificant increase in the HSP70 immunoexpression in the 
endometria collected in the secretory phase than in the proliferative phase of the 
menstrual cycle (data not shown). There was no obvious difference in HSP70 
expression in different anatomical locations of endometria (data not shown). There was 
no difference in the immunoexpression of HSP70 between eutopic and ectopic 
endometria derived from women with adenomyosis. 
Q-H scores of HSP70-immunoreactivity in adenomyosis and uterine myoma. 
Since there was no significant difference in HSP70 expression between gland cells and 
stromal cells, we represented combined data of Q-H scores of gland/stromal cells in the 
eutopic endometria or pathological lesions derived from control women and women 
with adenomyosis/uterine myoma (Figure 1, B). We found that Q-H scores of HSP70 
immunoreaction were significantly higher in the eutopic endometria/adenomyotic 
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lesions, eutopic endometria/myoma nodules and autologous myometria derived from 
women with adenomyosis and uterine myoma when compared with that of control 
endometria (p<0.05 for each of endometria, lesions and myometria)  (Figure 1, B). 
There was no obvious difference in the Q-H scores of HSP70 immunoreaction between 
adenomyotic lesions and myoma nodules or between surrounding myometria derived 
from women with adenomyosis and uterine myoma (Figure 1, B).  
 Co-localization of HSP70 with CD68-positive Mφ and VWF-positive 
micro-vessels. To identify co-localization of HSP70, CD68-stained Mφ, and 
VWF-stained micro-vessels, we extended our experiment using serial sections of each 
specimen derived from eutopic endometria and myometria of women with adenomyosis 
and uterine myoma. We found that HSP70 immunostaining was co-localized with 
VWF-stained micro-vessels and CD68-stained infiltrating Mφ in the parallel section of 
biopsy specimens derived from the eutopic endometria (Figure 2, A, B, C) and 
autologous myometria (Figure 2, D, E, F) derived from women with adenomyosis. We 
also observed a similar pattern of co-localization in the immunostaining of HSP70, 
VWF and CD68 in the endometria and myometria derived from control women and 
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women with uterine myoma (data not shown).      
Correlation between Q-H scores of HSP70 and CD68-positive Mφ. We 
examined the possible association between tissue stress reaction and the amount of 
infiltrated Mφ in tissues. We found a significant positive correlation between Q-H 
scores of HSP70-immunoreactive cells and CD68-positive Mφ numbers which was 
observed in the endometria derived from women with adenomyosis (r=0.388, p=0.0382) 
(Figure 3, B) but not in the endometria of control women (r=0.134) or in women with 
uterine myoma (r=0.082) (Figure 3, A, C). A similar pattern of positive correlation was 
observed between Q-H scores of HSP70 and VWF-positive micro-vessels or between 
Q-H scores of HSP70 and CD68-positive Mφ in the endometria/myometria, derived 
from women with adenomyosis but not in control women or women with uterine 
myoma (data not shown).   
Immunoexpression of HSP70 in tissues derived from GnRHa-treated and 
-untreated women with adenomyosis and uterine myoma. We found a moderate to 
strong immunoexpression of HSP70 in the endometria, myometria and adenomyotic 
lesions/myoma nodules derived from GnRHa-untreated women (Figure 4, A and B, 
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upper columns) comparing to similar samples derived from GnRHa-treated women 
(Figure 4, A and B, lower columns). 
Q-H scores of HSP70-immunoreactivity in tissues derived from 
GnRHa-treated and -untreated women with adenomyosis and uterine myoma. The 
Q-H scores of HSP70 immunoreactivity were found to be significantly decreased in the 
endometria, pathological lesions (adenomyotic lesions and myoma nodules) and 
autologous myometria derived from GnRHa-treated women (hatched bar) with 
adenomyosis and uterine myoma (Figure 4, C, D) when compared with similar tissues 
derived from GnRHa-untreated women (white bar) (Figure 4, C and D). 
The changes in the immunoreactivity of HSP70 expression in endometria, 
pathological lesions and myometria derived from GnRHa-treated and -untreated women 
with adenomyosis and uterine myoma are summarized in Table 2. Multiple ANCOVA 
with possible confounding variables as shown in Table 3 revealed that presence of 
adenomyotic lesions and myoma nodules were significantly and independently 
associated with the increased tissue expression of HSP70. Age was not an independent 
risk factor in increasing tissue expression of HSP70 in these two groups of women. This 
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difference in the tissue expression of HSP70 disappeared after GnRHa treatment (Table 
3). 
Discussion 
We demonstrated a variable degree of tissue stress reaction in the pathological 
lesions and eutopic endometria or autologous myometria derived from women with 
adenomyosis and uterine myoma. This was demonstrated by the over-expression of 
HSP70 in pathological lesions and eutopic endometria or myometria derived from these 
two groups of women. Similar to our previous in vitro study in women with 
endometriosis [6,7], here we further confirmed a significant association between stress 
reaction and inflammation and between stress reaction and angiogenesis in intact tissues 
derived from women adenomyosis. However, this association was not observed in 
control women and in women with uterine myoma. Our co-localization study confirmed 
that infiltrating Mφ and micro-vessels in tissues derived from these women also suffer 
from a variable amount of stress reaction. 
Besides inflammation, endometriosis, adenomyosis and uterine myoma may 
induce a variable degree of physical stress (cell to cell contact, cell proliferation, cell 
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differentiation or tissue invasion) or chemical stress (receptor-ligand interaction) in 
pelvic environment or within endometrium or myometrium. This constant inflammatory, 
physical or chemical insult at the tissue level may be involved in the higher expression 
of HSP70 in the eutopic endometrium as well as in different pathological lesions 
derived from women with adenomyosis and uterine myoma. Our current findings 
coincide with the previously published reports [1,6,19]. We previous reported decreased 
levels of cell proliferation, inflammation and angiogenesis in tissues derived from 
control women than in women with endometriosis [14,16]. A decreasing order of tissue 
inflammation, angiogenesis, and prostaglandin production was observed in submucosal 
myoma, intramural myoma, and in subserosal myoma [8]. Here, we did not separately 
analyze the pattern of HSP70 expression in each of these three types of uterine myoma 
due to small sample size. This could explain the reason why we did not find any 
positive association between HSP70 expression and CD68-positive Mφ or between 
HSP70 and VWF-positive micro-vessels in tissues derived from women with uterine 
myoma. Further studies using individual types of uterine myoma may clarify our 
findings. 
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Several reports have shown that heat shock proteins vary in accordance with 
the menstrual cycle. Tabibzadeh et al., [20] reported that constitutive form of HSP70 in 
human endometrium increased progressively during the late proliferative and early 
secretory phases, and diminished in the mid- to late secretory phases. Koshiyama et al.,
[21] found a markedly increased expression of HSP70 in human endometrium during 
the secretory phase. In our recent study in women with endometriosis [10], we found 
the highest expression of HSP70 in the menstrual phase, intermediate expression in the 
secretory phase and lower expression in the proliferative phase. In our present study, we 
did not find any significant difference in the tissue expression of HSP70 between the 
secretory phase and the proliferative phase of any of the control or study groups. This 
could be due to the difference in sample number or in our Q-H scoring system. 
Increased HSP70 protein expression in the endometria and pathological 
lesions of women with adenomyosis and uterine myoma carries some biological 
significance: (1) As a molecular chaperon, HSP70 inhibits apoptosis of host cells by 
preventing recruitment of caspases to the apoptosome complex [22]. Therefore, 
increased expression of HSP70 may contribute to increased survival of 
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endometrioid/smooth muscle cells thereby facilitating the growth of adenomoytic 
lesions or myoma lesions. While adenomyosis originates from direct invagination of 
gland cells of basalis endometrium into myometrium, myoma lesions originate from 
monoclonal expansion of a single smooth muscle cell in myometrium. Both of these 
lesions are associated with hyperplastic/hypertrophic change of surrounding smooth 
muscle cells. As a reactive tissue insult, the resulting hyperplastic or hypertrophic 
change of the surrounding myometrium could be an additional trigger to the 
over-expression of HSP70. (2) Persistent endogenous stimulation in 
endometria/myometria or in the pelvis with inflammation or HSP70 may change the cell 
membrane permeability causing efflux of different cytokines out of immune cells or 
may cause shifting of resting cells (S0) to proliferative phenotype (S2) in cell cycle. 
This may also result in increasing cytokine levels by Mφ  or increase in cell 
proliferation as we reported recently [7]. 
An interesting finding in our current study is that treatment with GnRHa was 
able to significantly suppress tissue expression of HSP70 in the pathological lesions, 
endometria and autologous myometria when compared with similar tissues derived 
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from GnRHa-untreated women with adenomyosis and uterine myoma. ANCOVA 
analysis further indicated that while presence of adenomyotic lesions and myoma 
nodules independently predicted over-expression of HSP70, this tissue stress insult was 
not observed after GnRHa treatment. Aside from central action and multiple biological 
functions of GnRHa in peripheral tissues [9], our results provided an additional effect of 
GnRHa on the suppression of tissue stress reaction in these reproductive diseases. 
GnRHa may decrease tissue inflammation secondary to decreased levels of tissue stress 
reaction either directly or indirectly by causing estrogen suppression. In fact, 
HSP70/estrogen-induced inflammatory and pro-inflammatory response has been 
recently demonstrated [6,7,23]. This may further explain the therapeutic benefit of 
GnRHa in alleviating pain manifestation or in improving reproductive outcome in 
women with adenomyosis and uterine myoma. 
There are some limitations in our current findings: (1) we did not analyze the 
pattern of HSP70 expression separately in focal/diffuse adenomyosis or in different 
types of uterine myoma. (2) Due to lack of samples during the menstrual phase, we 
could not examine menstrual phase-dependent changes in HSP70 expression, (3) we did 
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not measure tissue concentrations of soluble HSP70 and its link with tissue expression 
of HSP70 or with other inflammatory mediators. Further research is warranted to 
address these issues. 
Finally we conclude that besides endometriosis, women with adenomyosis and 
uterine myoma may also suffer from different in vivo tissue stress reaction. This stress 
insult was not confined to pathological lesions and corresponding 
endometria/myometria, but also to infiltrated immune cells and micro-vessels. Besides 
multiple biological functions in peripheral tissues, GnRHa treatment may have an 
additional beneficial effect on the suppression of tissue stress reaction. We propose that 
besides hormonal factors and inflammation, an in-depth investigation on the role of a 
variety of stress-reactive proteins including HSP70 in different reproductive diseases is 
necessary to support our current findings. 
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Figure legends 
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Figure 1. (A) Immunohistochemical staining of human heat shock protein 70 
(HSP70) in the control endometrium (a), and endometrium, adenomyotic lesion, and 
autologous myometrium of woman with adenomyosis (c, e, g, repsecitvely) and 
endometrium, myoma nodule, and autologous myometrium of woman with uterine 
myoma (d, f, h, respectively). HSP70 expression was observed in gland cells, stromal 
cells and in smooth muscle cells. Negative controls (non-immune mouse IgG stain) are 
shown against each endometria of control women (b), and women with adenomyosis (i) 
and uterine myoma (j). 
(B) Shows combined data of quantitative-histogram (Q-H) scores of HSP70 
immunoreactive gland/stromal cells derived from eutopic endometria/adenomyotic 
lesions (white box/hatched box) and in smooth muscle cells of nodule/myometria 
(hatched box) derived from women with adenomyosis and uterine myoma. Q-H scores 
of HSP70 immunoexpression in eutopic endometria/lesions/nodule/myometria derived 
from women with adenomyosis and uterine myoma were significantly higher when 
compared with eutopic endometria of control women (*p<0.05 for each). Boxes 
represent the distance (interquartile range) between the first (25%) and third (75%) 
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quartiles, and horizontal lines in the boxes represent median values. Magnification of 
each slide (x200). 
Figure 2. Co-localization of human heat shock protein 70 (HSP70)- 
immunostained cells (A, D), von Willebrand factor (VWF)-stained micro-vessels (B, E), 
and CD68-stained macrophages (C, F) at the same locations (arrows/arrow heads) in the 
serial sections of eutopic endometria (A, B, C, upper panel) and myometria (D, E, F, 
lower panel) derived from woman with adenomyosis (x400).  
Figure 3. The correlation between quantitative-histogram (Q-H) scores of 
human heat shock protein 70 (HSP70)-immunostained cells and CD68-immunoreactive 
mean macrophage (Mφ) numbers per field in the eutopic endometria derived from 
control women (A), in the eutopic endometria of women with adenomyosis (B), and in 
the eutopic endometria of women with uterine myoma (C). A significant positive 
correlation was found between Q-H scores of HSP70 expression and tissue infiltration 
of Mφ in women with adenomyosis (r=0.388, p=0.0382, B) but not in control women 
(A) or in women with uterine myoma (C) .       
Figure 4. The immunohistochemical staining of human heat shock protein 70 
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(HSP70) in the endometria, pathological lesions, and autologous myometria derived 
from GnRHa-untreated [GnRHa (-), upper columns] and GnRHa-treated [GnRHa (+), 
lower columns] women with adenomyosis (A) and uterine myoma (B). 
The quantitative-histogram (Q-H) scores of HSP70 immunoreactive cells in 
endometria, pathological lesions and autologous myometria derived from 
GnRHa-treated (hatched box) and -untreated (white box) women with adenomyosis (C) 
and uterine myoma (D). We found significantly lower Q-H scores of HSP70 expression 
in respective samples derived from GnRHa-treated women than in GnRHa-untreated 
women with adenomyosis and uterine myoma. Boxes represent the distance 
(interquartile range) between the first (25%) and third (75%) quartiles, and horizontal 
lines in the boxes represent median values. Magnification of each slide (A, B) (x200). 
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